Patent · US Active

Non-nucleoside reverse transcriptase inhibitors

US8486975B2 · kind B2 · utility

6Cited by
0References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 28, 2011
Grant dateJul 16, 2013
Priority date—
Expiry dateOct 7, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P31/18
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Heteroaromatic compounds of Formula I:are HIV reverse transcriptase inhibitors, wherein R1, R2, R3, R4 and R5 are defined herein. The compounds of Formula I and their pharmaceutically acceptable salts are useful in the inhibition of HIV reverse transcriptase, the prophylaxis and treatment of infection by HIV and in the prophylaxis, delay in the onset or progression, and treatment of AIDS. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.